The University of Chicago Header Logo

Connection

Wendy Stock to Trans-Activators

Back to Details
This is a "connection" page, showing publications Wendy Stock has written about Trans-Activators.
Wendy Stock
Connection Strength
0.235
Trans-Activators
  1. Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin. Blood. 2025 Jul 24; 146(4):471-481.
    View in: PubMed
    Score: 0.191
  2. Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. Nat Commun. 2024 May 01; 15(1):3681.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.